


This will be the SalesForce CRM for the Marijuana Industry
“Bakers customer relationship technology platform helps retailers create customer loyalty campaigns that consistently get more store visits and larger spend” Baker is an online pre-order and loyalty rewards for the cannabis industry. The industry is...
Meet the Bloomberg of the Marijuana Industry
New Frontier is the combination of Bloomberg and Gartner of cannabis, with the power of Salesforce to help those in and out of the cannabis industry navigate this new era.

Cannabis is the next disruptive technology
We don’t normally think of a plant as being a disruptive technology. But Cannabis will be highly disruptive to many industries. Think Pharmaceuticals…sleep aides, anxiety meds, gastrointestinal remedies, and pain. Think healthcare…epilepsy, MS, ALS,...
Here Are The Top 5 Financial Leaders In The Cannabis Industry
By: Debra Borchardt Investor dollars are pouring into the cannabis industry as it seems lots of people want to get in, but the level of investor and the amount they want to commit varies. A new survey from Marijuana Business Daily found that on average investors plan...
Picking Marijuana-Related Investments: Phyto Partners Walks Us Through Its Criteria
By: Javier Hasse Over the past few weeks, Benzinga has been sharing interviews with the top venture capital and investment firms operating in the cannabis industry. Among those focused on ancillary businesses that do not touch the plant, we profiled Snoop Dogg’s Casa...
Its All About SUPPLY
Supply will impact Pricing

Cannabis-As-A-Medicine (CAAM) is Real and the Economic Impact is Significant
A new study published in the journal called Health Affairs analyzed prescription drug usage in U.S. states where medical marijuana laws are in place. The study gathered Medicare data from 2010 – 2013 to see if patients were using cannabis to replace prescription drugs...
GW Pharmaceuticals Raising $252 Million is Watershed Moment for the Cannabis Industry
Something new just happened in the cannabis industry. GW Pharmaceuticals raised $252 million, post-capital raise, GW Pharmaceuticals will have $514 million in cash on hand. This ~$250mil raise, by a ~$3bil UK pharma company that exclusively produces, processes,...